HUP1800420A1 - Eljárás hatóanyagok agyba juttatására syndecan 3-on keresztül - Google Patents
Eljárás hatóanyagok agyba juttatására syndecan 3-on keresztülInfo
- Publication number
- HUP1800420A1 HUP1800420A1 HU1800420A HUP1800420A HUP1800420A1 HU P1800420 A1 HUP1800420 A1 HU P1800420A1 HU 1800420 A HU1800420 A HU 1800420A HU P1800420 A HUP1800420 A HU P1800420A HU P1800420 A1 HUP1800420 A1 HU P1800420A1
- Authority
- HU
- Hungary
- Prior art keywords
- active substances
- brain via
- transporting active
- syndecan
- via syndecan
- Prior art date
Links
- 102100026084 Syndecan-3 Human genes 0.000 title 1
- 108090000068 Syndecan-3 Proteins 0.000 title 1
- 239000013543 active substance Substances 0.000 title 1
- 210000004556 brain Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUP1800420A HU231426B1 (hu) | 2018-12-05 | 2018-12-05 | Syndecan-3 45-384 aminosav közti régiójára specifikus ligandok alkalmazása neurodegenerativ kórképek kezelésére |
PCT/HU2019/000041 WO2020115513A1 (en) | 2018-12-05 | 2019-12-05 | Brain targeted drug delivery method via syndecan-3 |
US17/311,193 US20220002433A1 (en) | 2018-12-05 | 2019-12-05 | Brain targeted drug delivery method via syndecan-3 |
EP19842611.6A EP3911362A1 (en) | 2018-12-05 | 2019-12-05 | Brain targeted drug delivery method via syndecan-3 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUP1800420A HU231426B1 (hu) | 2018-12-05 | 2018-12-05 | Syndecan-3 45-384 aminosav közti régiójára specifikus ligandok alkalmazása neurodegenerativ kórképek kezelésére |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP1800420A1 true HUP1800420A1 (hu) | 2020-06-29 |
HU231426B1 HU231426B1 (hu) | 2023-08-28 |
Family
ID=89992809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUP1800420A HU231426B1 (hu) | 2018-12-05 | 2018-12-05 | Syndecan-3 45-384 aminosav közti régiójára specifikus ligandok alkalmazása neurodegenerativ kórképek kezelésére |
Country Status (4)
Country | Link |
---|---|
US (1) | US20220002433A1 (hu) |
EP (1) | EP3911362A1 (hu) |
HU (1) | HU231426B1 (hu) |
WO (1) | WO2020115513A1 (hu) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU231462B1 (hu) * | 2020-07-22 | 2024-01-28 | Pharmacoidea Kf | Diagnosztikai eljárás az Alzheimer-kór vérből történő kimutatására |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2369936B1 (en) * | 2008-12-04 | 2018-01-24 | Lankenau Institute for Medical Research | Compositions and methods for the treatment and prevention of lens fibrotic diseases |
CA2938933A1 (en) * | 2014-03-12 | 2015-09-17 | Prothena Biosciences Limited | Anti-laminin4 antibodies specific for lg4-5 |
-
2018
- 2018-12-05 HU HUP1800420A patent/HU231426B1/hu unknown
-
2019
- 2019-12-05 EP EP19842611.6A patent/EP3911362A1/en active Pending
- 2019-12-05 US US17/311,193 patent/US20220002433A1/en active Pending
- 2019-12-05 WO PCT/HU2019/000041 patent/WO2020115513A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
HU231426B1 (hu) | 2023-08-28 |
EP3911362A1 (en) | 2021-11-24 |
US20220002433A1 (en) | 2022-01-06 |
WO2020115513A1 (en) | 2020-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11202006217YA (en) | Anti-claudin 18.2 antibodies | |
KR101904168B9 (ko) | 물류 배송방법 | |
PL3355682T3 (pl) | Sposób i aparat do formowania kilku bel i ich odkładania na podłoże w odpowiednich położeniach | |
KR102219955B9 (ko) | 빅데이터를 이용한 농생명 기반 플랫폼 시스템 | |
EP2975020A4 (en) | PROCESS FOR CLEANING 1,5-DIAMINOPENTANE | |
IL269850B (en) | Filter array and method for backwashing thereof | |
IL271399A (en) | Methods for the preparation of heterocyclic 3,1-benzodioxole compounds | |
ZA201901910B (en) | Therapeutic protein-loaded nanoparticle and method for preparing the same | |
SG10202110136XA (en) | Treatment for gingivitis | |
SG11202009175RA (en) | Silicon-terminated organo-metal compounds and processes for preparing the same | |
SG11202009138QA (en) | Silicon-terminated organo-metal compounds and processes for preparing the same | |
PL3484855T3 (pl) | Nowy związek benzyloamidowy, sposób jego wytwarzania i środek roztoczobójczy | |
HUP1800420A1 (hu) | Eljárás hatóanyagok agyba juttatására syndecan 3-on keresztül | |
PL3397620T3 (pl) | Sposób wytwarzania 1,1,3-triokso-1,2-benzotiazolo-6-karboksamidu | |
EP3560786A4 (en) | YUNITSKI TRANSPORT SYSTEM | |
EP3699287A4 (en) | 1,5-DIAMINOPENTANE PURIFICATION PROCESS | |
HK1244489A1 (zh) | P1,p4-二(尿苷5′)-四磷酸晶體的保存方法 | |
AP01024S1 (en) | Heart for 2 fetoscope | |
SG11202100269VA (en) | Compounds for use in the treatment of fascioliasis | |
PL3723521T3 (pl) | Jednostka zagęszczająca dla przemysłu tytoniowego | |
GB201907703D0 (en) | SEMMI travel system | |
GB201807084D0 (en) | Concept 33 | |
GB201807078D0 (en) | Concept 169 | |
GB201807117D0 (en) | Concept 32 | |
GB201807115D0 (en) | Concept 31 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |